Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 97 entries
Sorted by: Best Match Show Resources per page
Hyperleukocytosis in childhood acute lymphoblastic leukemia: complications and treatment outcome.

Turkish journal of haematology : official journal of Turkish Society of Haematology

İrken G, Ören H, Öniz H, Çetingül N, Vergin C, Atabay B, Gülen H, Türker M, Kantar M, Yılmaz Ş.
PMID: 27265481
Turk J Haematol. 2006 Sep 05;23(3):142-6.

Hyperleukocytosis, defined as a peripheral leukocyte count ≥ 100x109/L, is seen in 5-20% of newly diagnosed cases of childhood leukemia and is a poor prognostic factor. In this study, we aimed to examine the presenting clinical and laboratory features,...

Cite
İrken G, Ören H, Öniz H, et al. Çocukluk çağı akut lenfoblastik lösemisinde hiperlökositoz: komplikasyonlar, tedavi, prognoz. Hyperleukocytosis in childhood acute lymphoblastic leukemia: complications and treatment outcome. Turk J Haematol. 2006;23(3):142-6
İrken, G., Ören, H., Öniz, H., Çetingül, N., Vergin, C., Atabay, B., Gülen, H., Türker, M., Kantar, M., & Yılmaz, �. �. (2006). Çocukluk çağı akut lenfoblastik lösemisinde hiperlökositoz: komplikasyonlar, tedavi, prognoz. Hyperleukocytosis in childhood acute lymphoblastic leukemia: complications and treatment outcome. Turkish journal of haematology : official journal of Turkish Society of Haematology, 23(3), 142-6.
İrken, Gülersu, et al. "Çocukluk çağı akut lenfoblastik lösemisinde hiperlökositoz: komplikasyonlar, tedavi, prognoz." Hyperleukocytosis in childhood acute lymphoblastic leukemia: complications and treatment outcome. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 23,3 (2006): 142-6.
İrken G, Ören H, Öniz H, Çetingül N, Vergin C, Atabay B, Gülen H, Türker M, Kantar M, Yılmaz Ş. Çocukluk çağı akut lenfoblastik lösemisinde hiperlökositoz: komplikasyonlar, tedavi, prognoz. Hyperleukocytosis in childhood acute lymphoblastic leukemia: complications and treatment outcome. Turk J Haematol. 2006 Sep 05;23(3):142-6. PMID: 27265481.
Copy Download .nbib Format: NLM
Late Endocrine Side Effects in Children with Acute Leukemia.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Büyükavcı M, Çetingül N, Darcan Ş, Kantar M, Kavaklı K.
PMID: 27263478
Turk J Haematol. 2007 Mar 05;24(1):8-13.

This study was carried out in 28 patients (10 female, 18 male) diagnosed with acute leukemia, and aimed to investigate the abnormalities of endocrine system. Twenty-five of 28 patients were acute lymphoblastic leukemia and 3 were acute non-lymphocytic leukemia....

Cite
Büyükavcı M, Çetingül N, Darcan Ş, et al. Akut lösemili çocuklarda geç endokrin yan etkiler. Late Endocrine Side Effects in Children with Acute Leukemia. Turk J Haematol. 2007;24(1):8-13
Büyükavcı, M., Çetingül, N., Darcan, �. �., Kantar, M., & Kavaklı, K. (2007). Akut lösemili çocuklarda geç endokrin yan etkiler. Late Endocrine Side Effects in Children with Acute Leukemia. Turkish journal of haematology : official journal of Turkish Society of Haematology, 24(1), 8-13.
Büyükavcı, Mustafa, et al. "Akut lösemili çocuklarda geç endokrin yan etkiler." Late Endocrine Side Effects in Children with Acute Leukemia. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 24,1 (2007): 8-13.
Büyükavcı M, Çetingül N, Darcan Ş, Kantar M, Kavaklı K. Akut lösemili çocuklarda geç endokrin yan etkiler. Late Endocrine Side Effects in Children with Acute Leukemia. Turk J Haematol. 2007 Mar 05;24(1):8-13. PMID: 27263478.
Copy Download .nbib Format: NLM
Improvement in Paretic Arm Reach-to-Grasp following Low Frequency Repetitive Transcranial Magnetic Stimulation Depends on Object Size: A Pilot Study.

Stroke research and treatment

Tretriluxana J, Kantak S, Tretriluxana S, Wu AD, Fisher BE.
PMID: 26664827
Stroke Res Treat. 2015;2015:498169. doi: 10.1155/2015/498169. Epub 2015 Nov 17.

Introduction. Low frequency repetitive transcranial magnetic stimulation (LF-rTMS) delivered to the nonlesioned hemisphere has been shown to improve limited function of the paretic upper extremity (UE) following stroke. The outcome measures have largely included clinical assessments with little investigation...

Cite
Tretriluxana J, Kantak S, Tretriluxana S, et al. Improvement in Paretic Arm Reach-to-Grasp following Low Frequency Repetitive Transcranial Magnetic Stimulation Depends on Object Size: A Pilot Study. Stroke Res Treat. 2015;2015:498169doi: 10.1155/2015/498169.
Tretriluxana, J., Kantak, S., Tretriluxana, S., Wu, A. D., & Fisher, B. E. (2015). Improvement in Paretic Arm Reach-to-Grasp following Low Frequency Repetitive Transcranial Magnetic Stimulation Depends on Object Size: A Pilot Study. Stroke research and treatment, 2015498169. https://doi.org/10.1155/2015/498169
Tretriluxana, Jarugool, et al. "Improvement in Paretic Arm Reach-to-Grasp following Low Frequency Repetitive Transcranial Magnetic Stimulation Depends on Object Size: A Pilot Study." Stroke research and treatment vol. 2015 (2015): 498169. doi: https://doi.org/10.1155/2015/498169
Tretriluxana J, Kantak S, Tretriluxana S, Wu AD, Fisher BE. Improvement in Paretic Arm Reach-to-Grasp following Low Frequency Repetitive Transcranial Magnetic Stimulation Depends on Object Size: A Pilot Study. Stroke Res Treat. 2015;2015:498169. doi: 10.1155/2015/498169. Epub 2015 Nov 17. PMID: 26664827; PMCID: PMC4664821.
Copy Download .nbib Format: NLM
Chiral self-dimerization of vanadium complexes on a SiO2 surface: the first heterogeneous catalyst for asymmetric 2-naphthol coupling.

Chemical communications (Cambridge, England)

Tada M, Taniike T, Kantam LM, Iwasawa Y.
PMID: 15543270
Chem Commun (Camb). 2004 Nov 21;(22):2542-3. doi: 10.1039/b410307f. Epub 2004 Oct 04.

The self-dimerized chiral assembly of vanadium-Schiff-base complexes was found to occur on a SiO2 surface and to be the first heterogeneous catalyst for the asymmetric oxidative coupling of 2-naphthol with 100% selectivity and 90% enantioselectivity.

Cite
Tada M, Taniike T, Kantam LM, et al. Chiral self-dimerization of vanadium complexes on a SiO2 surface: the first heterogeneous catalyst for asymmetric 2-naphthol coupling. Chem Commun (Camb). 2004;(22):2542-3doi: 10.1039/b410307f.
Tada, M., Taniike, T., Kantam, L. M., & Iwasawa, Y. (2004). Chiral self-dimerization of vanadium complexes on a SiO2 surface: the first heterogeneous catalyst for asymmetric 2-naphthol coupling. Chemical communications (Cambridge, England), (22), 2542-3. https://doi.org/10.1039/b410307f
Tada, Mizuki, et al. "Chiral self-dimerization of vanadium complexes on a SiO2 surface: the first heterogeneous catalyst for asymmetric 2-naphthol coupling." Chemical communications (Cambridge, England) vol. ,22 (2004): 2542-3. doi: https://doi.org/10.1039/b410307f
Tada M, Taniike T, Kantam LM, Iwasawa Y. Chiral self-dimerization of vanadium complexes on a SiO2 surface: the first heterogeneous catalyst for asymmetric 2-naphthol coupling. Chem Commun (Camb). 2004 Nov 21;(22):2542-3. doi: 10.1039/b410307f. Epub 2004 Oct 04. PMID: 15543270.
Copy Download .nbib Format: NLM
Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation.

Analytical chemistry

Kantak AS, Srinivas M, Gale BK.
PMID: 16615764
Anal Chem. 2006 Apr 15;78(8):2557-64. doi: 10.1021/ac052127i.

Recent work with cyclical electrical field-flow fractionation systems has shown promise for the technique as a separation and analysis tool, but little is understood about how the carrier composition in the system affects its capabilities. The electrical properties of...

Cite
Kantak AS, Srinivas M, Gale BK. Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation. Anal Chem. 2006;78(8):2557-64doi: 10.1021/ac052127i.
Kantak, A. S., Srinivas, M., & Gale, B. K. (2006). Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation. Analytical chemistry, 78(8), 2557-64. https://doi.org/10.1021/ac052127i
Kantak, Ameya S, et al. "Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation." Analytical chemistry vol. 78,8 (2006): 2557-64. doi: https://doi.org/10.1021/ac052127i
Kantak AS, Srinivas M, Gale BK. Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation. Anal Chem. 2006 Apr 15;78(8):2557-64. doi: 10.1021/ac052127i. PMID: 16615764.
Copy Download .nbib Format: NLM
Cloning and identification of antimicrobial peptide, hepcidin from freshwater carp, .

3 Biotech

Banerjee R, Kanak K, Patel B, Samanta M, Das S.
PMID: 31497459
3 Biotech. 2019 Sep;9(9):341. doi: 10.1007/s13205-019-1874-6. Epub 2019 Aug 23.

Hepcidin, a cationic cysteine-rich antimicrobial peptide (AMP) acts in hormone regulation and iron homeostasis in the host body. However, the biological property of hepcidin in immune reaction remains unexplored. In aquatic milieu, environmental and pathogenic stressors cause detrimental infections,...

Cite
Banerjee R, Kanak K, Patel B, et al. Cloning and identification of antimicrobial peptide, hepcidin from freshwater carp, . 3 Biotech. 2019;9(9):341doi: 10.1007/s13205-019-1874-6.
Banerjee, R., Kanak, K., Patel, B., Samanta, M., & Das, S. (2019). Cloning and identification of antimicrobial peptide, hepcidin from freshwater carp, . 3 Biotech, 9(9), 341. https://doi.org/10.1007/s13205-019-1874-6
Banerjee, Rajanya, et al. "Cloning and identification of antimicrobial peptide, hepcidin from freshwater carp, ." 3 Biotech vol. 9,9 (2019): 341. doi: https://doi.org/10.1007/s13205-019-1874-6
Banerjee R, Kanak K, Patel B, Samanta M, Das S. Cloning and identification of antimicrobial peptide, hepcidin from freshwater carp, . 3 Biotech. 2019 Sep;9(9):341. doi: 10.1007/s13205-019-1874-6. Epub 2019 Aug 23. PMID: 31497459; PMCID: PMC6707987.
Copy Download .nbib Format: NLM
Kashmir in The Lancet.

Lancet (London, England)

Kantak A.
PMID: 31493893
Lancet. 2020 Sep 26;396(10255):e41. doi: 10.1016/S0140-6736(19)32073-2. Epub 2019 Sep 04.

No abstract available.

Cite
Kantak A. Kashmir in The Lancet. Lancet. 2019;396(10255):e41doi: 10.1016/S0140-6736(19)32073-2.
Kantak, A. (2020). Kashmir in The Lancet. Lancet (London, England), 396(10255), e41. https://doi.org/10.1016/S0140-6736(19)32073-2
Kantak, Avadhoot. "Kashmir in The Lancet." Lancet (London, England) vol. 396,10255 (2020): e41. doi: https://doi.org/10.1016/S0140-6736(19)32073-2
Kantak A. Kashmir in The Lancet. Lancet. 2020 Sep 26;396(10255):e41. doi: 10.1016/S0140-6736(19)32073-2. Epub 2019 Sep 04. PMID: 31493893.
Copy Download .nbib Format: NLM
Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: A review.

Carbohydrate polymers

Kantak MN, Bharate SS.
PMID: 34973801
Carbohydr Polym. 2022 Feb 15;278:118999. doi: 10.1016/j.carbpol.2021.118999. Epub 2021 Dec 09.

Chitosan is a modified natural carbohydrate polymer derived from chitin that occurs in many natural sources. It has a diverse range of applications in medical and pharmaceutical sciences. Its primary and permitted use is biomaterial in medical devices. Chitosan...

Cite
Kantak MN, Bharate SS. Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: A review. Carbohydr Polym. 2021;278:118999doi: 10.1016/j.carbpol.2021.118999.
Kantak, M. N., & Bharate, S. S. (2022). Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: A review. Carbohydrate polymers, 278118999. https://doi.org/10.1016/j.carbpol.2021.118999
Kantak, Maithili N, and Bharate, Sonali S. "Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: A review." Carbohydrate polymers vol. 278 (2022): 118999. doi: https://doi.org/10.1016/j.carbpol.2021.118999
Kantak MN, Bharate SS. Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: A review. Carbohydr Polym. 2022 Feb 15;278:118999. doi: 10.1016/j.carbpol.2021.118999. Epub 2021 Dec 09. PMID: 34973801.
Copy Download .nbib Format: NLM
Current view on novel vaccine technologies to combat human infectious diseases.

Applied microbiology and biotechnology

Matić Z, Šantak M.
PMID: 34889981
Appl Microbiol Biotechnol. 2021 Dec 10; doi: 10.1007/s00253-021-11713-0. Epub 2021 Dec 10.

Inactivated and live attenuated vaccines have improved human life and significantly reduced morbidity and mortality of several human infectious diseases. However, these vaccines have faults, such as reactivity or suboptimal efficacy and expensive and time-consuming development and production. Additionally,...

Cite
Matić Z, Šantak M. Current view on novel vaccine technologies to combat human infectious diseases. Appl Microbiol Biotechnol. 2021;doi: 10.1007/s00253-021-11713-0.
Matić, Z., & Šantak, M. (2021). Current view on novel vaccine technologies to combat human infectious diseases. Applied microbiology and biotechnology, . https://doi.org/10.1007/s00253-021-11713-0
Matić, Zrinka, and Šantak, Maja. "Current view on novel vaccine technologies to combat human infectious diseases." Applied microbiology and biotechnology vol. (2021). doi: https://doi.org/10.1007/s00253-021-11713-0
Matić Z, Šantak M. Current view on novel vaccine technologies to combat human infectious diseases. Appl Microbiol Biotechnol. 2021 Dec 10; doi: 10.1007/s00253-021-11713-0. Epub 2021 Dec 10. PMID: 34889981; PMCID: PMC8661323.
Copy Download .nbib Format: NLM
Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation.

The Journal of dermatology

Miyazaki M, Ohkawa N, Miyabayashi K, Shoji H, Takeichi T, Kantake M, Akiyama M, Shimizu T.
PMID: 34904281
J Dermatol. 2021 Dec 13; doi: 10.1111/1346-8138.16277. Epub 2021 Dec 13.

No abstract available.

Cite
Miyazaki M, Ohkawa N, Miyabayashi K, et al. Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation. J Dermatol. 2021;doi: 10.1111/1346-8138.16277.
Miyazaki, M., Ohkawa, N., Miyabayashi, K., Shoji, H., Takeichi, T., Kantake, M., Akiyama, M., & Shimizu, T. (2021). Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation. The Journal of dermatology, . https://doi.org/10.1111/1346-8138.16277
Miyazaki, Moeka, et al. "Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation." The Journal of dermatology vol. (2021). doi: https://doi.org/10.1111/1346-8138.16277
Miyazaki M, Ohkawa N, Miyabayashi K, Shoji H, Takeichi T, Kantake M, Akiyama M, Shimizu T. Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation. J Dermatol. 2021 Dec 13; doi: 10.1111/1346-8138.16277. Epub 2021 Dec 13. PMID: 34904281.
Copy Download .nbib Format: NLM
Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients.

Research and practice in thrombosis and haemostasis

Stals M, Grootenboers M, van Guldener C, Kaptein F, Braken S, Chen Q, Chu G, van Driel EM, Iglesias Del Sol A, de Jonge E, Kant KM, Pals F, Toorop M, Cannegieter SC, Klok FA, Huisman MV.
PMID: 33821230
Res Pract Thromb Haemost. 2021 Feb 17; doi: 10.1002/rth2.12496. Epub 2021 Feb 17.

BACKGROUND: Whereas accumulating studies on COVID-19 patients report high incidences of thrombotic complications, large studies on clinically relevant thrombosis in patients with other respiratory tract infections are lacking. How this high risk in COVID-19 patients compares to those observed...

Cite
Stals M, Grootenboers M, van Guldener C, et al. Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients. Res Pract Thromb Haemost. 2021;doi: 10.1002/rth2.12496.
Stals, M., Grootenboers, M., van Guldener, C., Kaptein, F., Braken, S., Chen, Q., Chu, G., van Driel, E. M., Iglesias Del Sol, A., de Jonge, E., Kant, K. M., Pals, F., Toorop, M., Cannegieter, S. C., Klok, F. A., Huisman, M. V. (2021). Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients. Research and practice in thrombosis and haemostasis, . https://doi.org/10.1002/rth2.12496
Stals, Mam, et al. "Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients." Research and practice in thrombosis and haemostasis vol. (2021). doi: https://doi.org/10.1002/rth2.12496
Stals M, Grootenboers M, van Guldener C, Kaptein F, Braken S, Chen Q, Chu G, van Driel EM, Iglesias Del Sol A, de Jonge E, Kant KM, Pals F, Toorop M, Cannegieter SC, Klok FA, Huisman MV. Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients. Res Pract Thromb Haemost. 2021 Feb 17; doi: 10.1002/rth2.12496. Epub 2021 Feb 17. PMID: 33821230; PMCID: PMC8014477.
Copy Download .nbib Format: NLM
Larvicidal Activities against .

Tropical medicine and infectious disease

Katak RM, Rocha EM, Oliveira JC, Muniz VA, Oliveira MR, Ferreira FAS, Silva WR, Roque RA, de Souza AQL, Souza-Neto JA, Terenius O, Marinotti O, Tadei WP.
PMID: 34204476
Trop Med Infect Dis. 2021 Jun 17;6(2). doi: 10.3390/tropicalmed6020104.

The

Cite
Katak RM, Rocha EM, Oliveira JC, et al. Larvicidal Activities against . Trop Med Infect Dis. 2021;6(2)doi: 10.3390/tropicalmed6020104.
Katak, R. M., Rocha, E. M., Oliveira, J. C., Muniz, V. A., Oliveira, M. R., Ferreira, F. A. S., Silva, W. R., Roque, R. A., de Souza, A. Q. L., Souza-Neto, J. A., Terenius, O., Marinotti, O., & Tadei, W. P. (2021). Larvicidal Activities against . Tropical medicine and infectious disease, 6(2), . https://doi.org/10.3390/tropicalmed6020104
Katak, Ricardo M, et al. "Larvicidal Activities against ." Tropical medicine and infectious disease vol. 6,2 (2021). doi: https://doi.org/10.3390/tropicalmed6020104
Katak RM, Rocha EM, Oliveira JC, Muniz VA, Oliveira MR, Ferreira FAS, Silva WR, Roque RA, de Souza AQL, Souza-Neto JA, Terenius O, Marinotti O, Tadei WP. Larvicidal Activities against . Trop Med Infect Dis. 2021 Jun 17;6(2). doi: 10.3390/tropicalmed6020104. PMID: 34204476; PMCID: PMC8293452.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 97 entries